Abeyagunawardena Asiri S, Sebire Neil J, Risdon R Anthony, Dillon Michael J, Rees Lesley, Van't Hoff William, Kumarasiri Pallegoda V, Trompeter Richard S
Nephro-Urology Unit, Great Ormond Street Hospital NHS Trust, London, WC1N 3JH, UK.
Pediatr Nephrol. 2007 Feb;22(2):215-21. doi: 10.1007/s00467-006-0264-6. Epub 2006 Dec 5.
Clinical and histological data of children presenting with steroid-resistant nephrotic syndrome and renal biopsy showing focal and segmental glomerulosclerosis from 1980 with a follow-up of over 10 years were reviewed. There were 66 patients; 38 male and 28 female. Age at onset ranged from 0.4-14.1 years (mean 6.4). Tubular atrophy was present at first biopsy in 50/66, capsular adhesions in 35/66, glomerular tip lesions in 8/66 and mesangial expansion in 31/66 patients. In 51 children, cyclophosphamide was prescribed as the first cytotoxic agent, while 15 received cyclosporine A and complete remission was induced in 43 and 40% of the children, respectively. Complete and stable remission was maintained in 35 children, while 22 had reduction of proteinuria with symptomatic relief. Nine were refractory to cytotoxic therapy. Of the 35 patients who entered complete and stable remission, the renal survival was over 90%, while in the 31 non-responders it was 48% in 10 years. The multivariate analysis using unconditional logistic regression method identified the presence of mesangial expansion (p=0.011) and tip lesions (p=0.005) as the independent predictors of favourable response to cytotoxic therapy and the presence of renal impairment (p=0.008) and extensive focal segmental sclerosis (p=0.025) as independent predictors of unfavourable response.
回顾了1980年以来出现激素抵抗型肾病综合征且肾活检显示局灶节段性肾小球硬化的儿童的临床和组织学数据,并进行了超过10年的随访。共有66例患者,其中男性38例,女性28例。发病年龄在0.4至14.1岁之间(平均6.4岁)。首次活检时,66例患者中有50例存在肾小管萎缩,35例存在包膜粘连,8例存在肾小球顶端病变,31例存在系膜扩张。51名儿童首次使用环磷酰胺作为细胞毒性药物,15名使用环孢素A,分别有43%和40%的儿童诱导完全缓解。35名儿童维持了完全稳定的缓解,22名儿童蛋白尿减少且症状缓解。9名儿童对细胞毒性治疗无效。在进入完全稳定缓解的35例患者中,肾脏存活率超过90%,而在31例无反应者中,10年肾脏存活率为48%。使用无条件逻辑回归方法进行的多变量分析确定,系膜扩张(p=0.011)和顶端病变(p=0.005)是细胞毒性治疗良好反应的独立预测因素,而肾功能损害(p=0.008)和广泛的局灶节段性硬化(p=0.025)是不良反应的独立预测因素。